The average age of men who get diagnosed is 67.
Study shows lower risk for multiple myeloma as well as pancreatic, prostate, breast and kidney cancers ...
Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...
MedPage Today on MSN
Two Types of ADT for Prostate Cancer, Different Effects on Coronary Artery Plaque
Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...
One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...
6d
A landmark 'evolutionary double-bind' strategy to overcome treatment resistance in prostate cancer
Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...
A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results